ACRO Releases New Report on the Past, Present, and Future of Risk-Based Monitoring
Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality. To better understand implementation across the industry, the Association of Clinical Research Organizations (ACRO) conducted a landscape survey of RBM implementation across 6,513 clinical trials that were ongoing in 2019 and compiled the information in a comprehensive report.
After an unprecedented year, the clinical research industry has proved innovative, even in difficult circumstances. ACRO s latest report highlights a significant shift to risk-based monitoring, titled
Risk-based Monitoring in Clinical Trials: Past, Present Future. It also supports the industry shift towards a more holistic Risk Based Quality Management (RBQM) system.
More Than 100 Companies Adopt eClinical Solutions’ elluminate® Clinical Data Platform to Increase Clinical Trial Efficiency
Share Article
Life sciences technology platform provider builds on demand for modern data pipelines, faster review and analytics and expands senior leadership With technology platforms like elluminate, we can build on the industry-wide advances made during the pandemic, help manage the data streams coming from decentralized trials and deliver new and important treatments to patients, said Raj Indupuri, Co-Founder and CEO of eClinical Solutions. MANSFIELD, Mass. (PRWEB) February 11, 2021
eClinical Solutions LLC, a global provider of cloud-based enterprise software and software-driven clinical data services, today announced a more than 40-percent annual license growth of its elluminate® Clinical Data Platform in 2020. This brings the total global adoption of elluminate to over 100 life s
Risk-based Monitoring (RBM) Software Market to Reach a Value of USD 644.6 Million by 2027 | Rise in Outsourcing of Clinical Trials to Contract Research Organizations will Drive the Industry Growth, says Emergen Research Increasing demand for monitoring solutions to resolve issues during clinical trials and rising number of clinical trials globally is driving growth of the risk-based monitoring (RBM) software market.
January 19, 2021 19:00 ET | Source: Emergen Research Emergen Research Surrey, CANADA
Vancouver, British Columbia, Jan. 19, 2021 (GLOBE NEWSWIRE) The global risk-based monitoring (RBM) software market is projected to reach a market size of USD 644.6 Million by 2027 at a steady CAGR during the forecast period, according to most recent analysis by Emergen Research. Due to the increased number of clinical trials globally, the global risk-based monitoring (RBM) software market revenue growth is expected